Anti Retroviral Market Overview:
A retrovirus is a group of viruses related to the Retroviridae family that perform their genetic blueprint in the form of ribonucleic acid RNA. Anti-retroviral drugs prevent these viruses from multiplying rather than killing them. Anti-retroviral drugs are medicines for the treatment of retroviral infection, mainly HIV. The global market for antiretroviral drugs is anticipated to record a CAGR of 4.0% during the forecast period 2018-2025.
Request a Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/anti-retroviral-drugs-market
Increasing Prevalence of HIV:
According to the United States Health & Human Services Department, around 36.7 million individuals globally were living with HIV / AIDS, of which 2.1 million were children. An estimated 1.8 million people worldwide were newly infected with HIV in 2016. Anti-retrovirals ARVs are the foundation of HIV / AIDS management, as there is currently no cure or vaccine available for HIV. In people with a non-resistant HIV strain, antiretroviral treatment can suppress HIV replication in about 80% of cases. This huge patient pool shows that in the forecast period, the market for anti-retroviral drugs will grow at a rapid CAGR. Increasing investment in antiviral R&D, increasing prevalence rate of retroviral diseases, and high unmet people’s needs are some of the other factors contributing to market growth.
Side Effects of Drugs:
There have been noted side effects of antiretroviral drugs in some patients, such as loss of appetite, lipodystrophy, diarrhea, fatigue, and high triglyceride & cholesterol levels, and there has been a pressing concern that needs to be addressed. In addition, the lack of effective drugs and increasing drug candidates’ failure rate also restrict the growth of the anti-retroviral drugs market.
Get Detailed Information about this Research Report @ https://www.planetmarketreports.com/reports/anti-retroviral-drugs-market
North America is dominating the market growth
The report on antiretroviral drugs is segmented by drug type and geography. It is segmented by geography into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Due to better healthcare infrastructure and R&D capabilities, North America dominates the market.
Major Players: Roche, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott, AstraZeneca, Merck, Johnson and Johnson, Boehringer Ingelheim, and Novartis AG, among others.
Name: Jennifer Daniel
Organization: Planet Market Reports